Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China
· Delayed Price · Currency is CNY 27.80
-0.14 (-0.50%)
Mar 9, 2026, 3:04 PM CST
SHE:002773 Revenue
Chengdu Kanghong Pharmaceutical Group had revenue of 1.17B CNY in the quarter ending September 30, 2025, with 4.75% growth. This brings the company's revenue in the last twelve months to 4.67B, up 6.76% year-over-year. In the year 2024, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.45B with 12.51% growth.
Revenue (ttm)
4.67B
Revenue Growth
+6.76%
P/S Ratio
5.49
Revenue / Employee
1.05M
Employees
4,462
Market Cap
25.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.45B | 495.20M | 12.51% |
| Dec 31, 2023 | 3.96B | 568.43M | 16.77% |
| Jan 1, 2023 | 3.39B | -216.32M | -6.00% |
| Jan 1, 2022 | 3.61B | 309.92M | 9.40% |
| Dec 31, 2020 | 3.30B | 38.00M | 1.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Kangmei Pharmaceutical | 5.28B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Livzon Pharmaceutical Group | 11.85B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Dizal (Jiangsu) Pharmaceutical | 801.14M |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 5.37B |